TABLE 3.
Relative risk of resistance to foscarnet or cidofovir while undergoing treatment with foscarnet or cidofovir, respectively, versus risk of resistance to ganciclovir while on ganciclovir
Drug | Isolate source | Relative risk | 95% CI |
---|---|---|---|
Foscarnet | Blood | 1.62 | 0.59–4.40 |
Urine | 1.50 | 0.27–8.28 | |
Blood or urine | 1.87 | 0.73–4.78 | |
Cidofovir | Blood | 3.44 | 0.88–13.41 |
Urine | 1.09 | 0.13–8.88 | |
Blood or urine | 2.28 | 0.75–6.95 |